25 Apr2024Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation CancerAuthor By Healthufit Posted on April 25, 2024April 25, 2024Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-base...